In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
Hayakawa
K
K
Department of Radiology, Kyoto City Hospital, Japan.
Yamashita
K
K
Mitsumori
M
M
Nakano
Y
Y
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000000981:diagnostic imaging*; D003287:Contrast Media / Q000633:toxicity*; D003974:Diatrizoate Meglumine / Q000633:toxicity; D005260:Female; D005682:Gadolinium; D019786:Gadolinium DTPA; D007472:Iohexol / Q000633:toxicity; D007485:Ioxaglic Acid / Q000633:toxicity; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D009942:Organometallic Compounds; D009994:Osmolar Concentration; D004369:Pentetic Acid; D011817:Rabbits; D011859:Radiography; D014283:Triiodobenzoic Acids / Q000633:toxicity
D003287:Contrast Media; D009942:Organometallic Compounds; D014283:Triiodobenzoic Acids; C033300:iotrolan; D003974:Diatrizoate Meglumine; D007472:Iohexol; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA; D007485:Ioxaglic Acid